Lab Testing Transparency will Improve Patient Care and Lower Costs

In the news

Avalon’s CEO Bill Kerr, M.D., shares in a MedCity News article why lab testing price transparency and payment integrity programs should be priorities as the U.S. healthcare industry
continues to advance value-based care and population health.

Read more by visiting MedCityNews.

bill kerr headshot
Register here for the
January Webinar

Tuesday, January 23
2 – 3 p.m. EST

Connect With Us

Want to get in touch? We’d love to hear from you.